COVID-19 vaccine uptake among young adults: Influence of asthma and sociodemographic factors.

COVID-19 vaccine uptake among young adults: Influence of asthma and sociodemographic factors.

Publication date: May 01, 2024

Asthma was initially described as a risk factor for severe coronavirus disease 2019 (COVID-19), but the uptake of COVID-19 vaccine among young adults with asthma is not well studied. The aims were to assess COVID-19 vaccine uptake among young adults in general and to explore potential determinants including sociodemographic factors and asthma. Participants from the population-based birth cohort BAMSE (Barn/Child, Allergy, Milieu, Stockholm, Epidemiology) were included: 4,064 in the study population, 3,064 in a follow-up at age 24 years, and 2,049 in a COVID-19 follow-up (mean age, 26. 5 years). Asthma and asthma-associated characteristics were assessed through questionnaires and clinical data. Data on all COVID-19 vaccines registered between January 1, 2021, and February 15, 2023, were extracted from the National Vaccination Register. In the study population (n = 4,064), 53. 9% had ≥3 COVID-19 vaccine doses registered. In the 24-year follow-up population (n = 3,064), vaccine uptake differed in relation to education (P < .001). Among the participants with university/college education, 65. 7% had an uptake of ≥3 doses of vaccine, compared to 54. 1% among the participants with elementary school/high school education. Participants with asthma had decreased odds of receiving ≥3 doses (adjusted odds ratio = 0. 62; 95% confidence interval, 0. 41-0. 92) and ≥2 compared to peers without asthma. Those with uncontrolled disease also had decreased odds of receiving ≥3 doses (adjusted odds ratio = 0. 30; 95% confidence interval, 0. 13-0. 66) and ≥2 compared to participants with controlled asthma. COVID-19 vaccine uptake among young adults is lower in individuals from households with lower socioeconomic status and among those with asthma, including uncontrolled asthma.

Concepts Keywords
Barn allergic disease
Coronavirus Asthma control
February birth cohort
Socioeconomic comorbidity
population based
SARS-CoV-2
severity
vaccination

Semantics

Type Source Name
disease VO COVID-19 vaccine
disease MESH asthma
pathway KEGG Asthma
disease MESH coronavirus disease 2019
disease VO population
disease MESH Allergy
disease VO vaccination
disease VO vaccine
disease MESH Long Covid
disease MESH comorbidity

Original Article

(Visited 1 times, 1 visits today)